Emerald Advisers’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,736
| Closed | -$206K | – | 261 |
|
|
2024
Q2 | $206K | Sell |
1,736
-1,464
| -46% | -$174K | 0.01% | 210 |
|
|
2024
Q1 | $341K | Sell |
3,200
-1,936
| -38% | -$206K | 0.01% | 197 |
|
|
2023
Q4 | $511K | Buy |
5,136
+2,615
| +104% | +$260K | 0.02% | 174 |
|
|
2023
Q3 | $260K | Buy |
+2,521
| New | +$260K | 0.01% | 200 |
|
|
2021
Q2 | – | Sell |
-6,046
| Closed | -$792K | – | 298 |
|
|
2021
Q1 | $792K | Buy |
6,046
+690
| +13% | +$90.4K | 0.03% | 166 |
|
|
2020
Q4 | $560K | Sell |
5,356
-1,846
| -26% | -$193K | 0.02% | 189 |
|
|
2020
Q3 | $510K | Buy |
7,202
+2,072
| +40% | +$147K | 0.02% | 183 |
|
|
2020
Q2 | $329K | Buy |
+5,130
| New | +$329K | 0.01% | 200 |
|